跳至主要内容
临床试验/ISRCTN10619673
ISRCTN10619673进行中(未招募)未知

A prospective observational multicenter study of HF10 therapy using surgical leads

evro Corp0 个研究点目标入组 339 人开始时间: 2019年10月22日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
339

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Have chronic intractable back pain and/or leg pain of neuropathic origin, as determined by the physician
  • 2. An appropriate candidate for spinal cord stimulation and/or surgical lead placement as determined by the physician
  • 3. Already scheduled for either a commercial trial with Nevro or a permanent implant of the Senza system (with surgical lead only)
  • 4. Be 18 years of age or older at the time of enrollment
  • 5. Be able to read and understand the Patient Informed Consent Form
  • 6. Be willing and capable of giving informed consent

排除标准

  • 1. Contraindicated for surgical lead placement and/or spinal cord stimulation; physician should reference labeling for precautions, warnings and indications

研究者

发起方
evro Corp

相似试验